 | • レポートコード：QFJ1-4123 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、糖尿病性胃不全麻痺の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、外科治療製品）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・糖尿病性胃不全麻痺の市場動向 ・企業の競争状況、市場シェア ・糖尿病性胃不全麻痺の種類別市場規模と予測2016-2027（医薬品、外科治療製品） ・糖尿病性胃不全麻痺の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・糖尿病性胃不全麻痺の北米市場規模2016-2027（アメリカ、カナダ） ・糖尿病性胃不全麻痺の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・糖尿病性胃不全麻痺のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・糖尿病性胃不全麻痺の中南米市場規模2016-2027（メキシコ、ブラジル） ・糖尿病性胃不全麻痺の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Medtronic、Sumitomo Dainippon Pharma、Abbott Laboratories、Boston Scientific Corporation、C. R. Bard, Inc、Janssen Global Services, LLC、Alfasigma SpA、Evoke Pharma、Cadila Pharmaceuticals、Sanofi、Teva Pharmaceutical Industries Ltd、Pfizer、Vanda Pharmaceuticals、Allergan） ・結論 |
Diabetes type 1 and type 2 are one of the most common chronic diseases prevalent in the world, affecting millions of people. One of the disorders associated with diabetes type 1 and type 2 is gastroparesis, which is characterized by the delayed emptying of the stomach. One of the major causes of gastroparesis is damage to the vagus nerve, reducing the mobility of the stomach contents. Diabetic neuropathy affects the vagus nerve, in cases where the blood glucose levels remain high over a longer duration. Diabetes gastroparesis is usually diagnosed with the help of imaging techniques such as ultrasound and x-ray, which is accompanied by the intake of radio isotopic meals containing barium, or using hematological / blood tests, and endoscopic techniques. There has been a marked increase in the prevalence of diabetes, especially in the developing countries, including China, India, Brazil, and some other Asian countries, leading to increasing incidence of diabetic neuropathy and consequent rise in diabetes gastroparesis around the world.
Market Analysis and Insights: Global Diabetic Gastroparesis Market
The global Diabetic Gastroparesis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetic Gastroparesis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetic Gastroparesis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetic Gastroparesis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetic Gastroparesis market.
Global Diabetic Gastroparesis Scope and Market Size
Diabetic Gastroparesis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Gastroparesis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Distribution Channel in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Drugs
Surgical Treatment Products
Segment by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Medtronic
Sumitomo Dainippon Pharma
Abbott Laboratories
Boston Scientific Corporation
C. R. Bard, Inc
Janssen Global Services, LLC
Alfasigma SpA
Evoke Pharma
Cadila Pharmaceuticals
Sanofi
Teva Pharmaceutical Industries Ltd
Pfizer
Vanda Pharmaceuticals
Allergan
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Gastroparesis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs
1.2.3 Surgical Treatment Products
1.3 Market by Application
1.3.1 Global Diabetic Gastroparesis Market Share by Distribution Channel: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Gastroparesis Market Perspective (2016-2027)
2.2 Diabetic Gastroparesis Growth Trends by Regions
2.2.1 Diabetic Gastroparesis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetic Gastroparesis Historic Market Share by Regions (2016-2021)
2.2.3 Diabetic Gastroparesis Forecasted Market Size by Regions (2022-2027)
2.3 Diabetic Gastroparesis Industry Dynamic
2.3.1 Diabetic Gastroparesis Market Trends
2.3.2 Diabetic Gastroparesis Market Drivers
2.3.3 Diabetic Gastroparesis Market Challenges
2.3.4 Diabetic Gastroparesis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetic Gastroparesis Players by Revenue
3.1.1 Global Top Diabetic Gastroparesis Players by Revenue (2016-2021)
3.1.2 Global Diabetic Gastroparesis Revenue Market Share by Players (2016-2021)
3.2 Global Diabetic Gastroparesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetic Gastroparesis Revenue
3.4 Global Diabetic Gastroparesis Market Concentration Ratio
3.4.1 Global Diabetic Gastroparesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Gastroparesis Revenue in 2020
3.5 Diabetic Gastroparesis Key Players Head office and Area Served
3.6 Key Players Diabetic Gastroparesis Product Solution and Service
3.7 Date of Enter into Diabetic Gastroparesis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Gastroparesis Breakdown Data by Type
4.1 Global Diabetic Gastroparesis Historic Market Size by Type (2016-2021)
4.2 Global Diabetic Gastroparesis Forecasted Market Size by Type (2022-2027)
5 Diabetic Gastroparesis Breakdown Data by Distribution Channel
5.1 Global Diabetic Gastroparesis Historic Market Size by Distribution Channel (2016-2021)
5.2 Global Diabetic Gastroparesis Forecasted Market Size by Distribution Channel (2022-2027)
6 North America
6.1 North America Diabetic Gastroparesis Market Size (2016-2027)
6.2 North America Diabetic Gastroparesis Market Size by Type
6.2.1 North America Diabetic Gastroparesis Market Size by Type (2016-2021)
6.2.2 North America Diabetic Gastroparesis Market Size by Type (2022-2027)
6.2.3 North America Diabetic Gastroparesis Market Size by Type (2016-2027)
6.3 North America Diabetic Gastroparesis Market Size by Distribution Channel
6.3.1 North America Diabetic Gastroparesis Market Size by Distribution Channel (2016-2021)
6.3.2 North America Diabetic Gastroparesis Market Size by Distribution Channel (2022-2027)
6.3.3 North America Diabetic Gastroparesis Market Size by Distribution Channel (2016-2027)
6.4 North America Diabetic Gastroparesis Market Size by Country
6.4.1 North America Diabetic Gastroparesis Market Size by Country (2016-2021)
6.4.2 North America Diabetic Gastroparesis Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Diabetic Gastroparesis Market Size (2016-2027)
7.2 Europe Diabetic Gastroparesis Market Size by Type
7.2.1 Europe Diabetic Gastroparesis Market Size by Type (2016-2021)
7.2.2 Europe Diabetic Gastroparesis Market Size by Type (2022-2027)
7.2.3 Europe Diabetic Gastroparesis Market Size by Type (2016-2027)
7.3 Europe Diabetic Gastroparesis Market Size by Distribution Channel
7.3.1 Europe Diabetic Gastroparesis Market Size by Distribution Channel (2016-2021)
7.3.2 Europe Diabetic Gastroparesis Market Size by Distribution Channel (2022-2027)
7.3.3 Europe Diabetic Gastroparesis Market Size by Distribution Channel (2016-2027)
7.4 Europe Diabetic Gastroparesis Market Size by Country
7.4.1 Europe Diabetic Gastroparesis Market Size by Country (2016-2021)
7.4.2 Europe Diabetic Gastroparesis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Diabetic Gastroparesis Market Size (2016-2027)
8.2 Asia-Pacific Diabetic Gastroparesis Market Size by Type
8.2.1 Asia-Pacific Diabetic Gastroparesis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetic Gastroparesis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetic Gastroparesis Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetic Gastroparesis Market Size by Distribution Channel
8.3.1 Asia-Pacific Diabetic Gastroparesis Market Size by Distribution Channel (2016-2021)
8.3.2 Asia-Pacific Diabetic Gastroparesis Market Size by Distribution Channel (2022-2027)
8.3.3 Asia-Pacific Diabetic Gastroparesis Market Size by Distribution Channel (2016-2027)
8.4 Asia-Pacific Diabetic Gastroparesis Market Size by Region
8.4.1 Asia-Pacific Diabetic Gastroparesis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetic Gastroparesis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Diabetic Gastroparesis Market Size (2016-2027)
9.2 Latin America Diabetic Gastroparesis Market Size by Type
9.2.1 Latin America Diabetic Gastroparesis Market Size by Type (2016-2021)
9.2.2 Latin America Diabetic Gastroparesis Market Size by Type (2022-2027)
9.2.3 Latin America Diabetic Gastroparesis Market Size by Type (2016-2027)
9.3 Latin America Diabetic Gastroparesis Market Size by Distribution Channel
9.3.1 Latin America Diabetic Gastroparesis Market Size by Distribution Channel (2016-2021)
9.3.2 Latin America Diabetic Gastroparesis Market Size by Distribution Channel (2022-2027)
9.3.3 Latin America Diabetic Gastroparesis Market Size by Distribution Channel (2016-2027)
9.4 Latin America Diabetic Gastroparesis Market Size by Country
9.4.1 Latin America Diabetic Gastroparesis Market Size by Country (2016-2021)
9.4.2 Latin America Diabetic Gastroparesis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetic Gastroparesis Market Size (2016-2027)
10.2 Middle East & Africa Diabetic Gastroparesis Market Size by Type
10.2.1 Middle East & Africa Diabetic Gastroparesis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetic Gastroparesis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetic Gastroparesis Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetic Gastroparesis Market Size by Distribution Channel
10.3.1 Middle East & Africa Diabetic Gastroparesis Market Size by Distribution Channel (2016-2021)
10.3.2 Middle East & Africa Diabetic Gastroparesis Market Size by Distribution Channel (2022-2027)
10.3.3 Middle East & Africa Diabetic Gastroparesis Market Size by Distribution Channel (2016-2027)
10.4 Middle East & Africa Diabetic Gastroparesis Market Size by Country
10.4.1 Middle East & Africa Diabetic Gastroparesis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetic Gastroparesis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Diabetic Gastroparesis Introduction
11.1.4 Medtronic Revenue in Diabetic Gastroparesis Business (2016-2021)
11.1.5 Medtronic Recent Development
11.2 Sumitomo Dainippon Pharma
11.2.1 Sumitomo Dainippon Pharma Company Details
11.2.2 Sumitomo Dainippon Pharma Business Overview
11.2.3 Sumitomo Dainippon Pharma Diabetic Gastroparesis Introduction
11.2.4 Sumitomo Dainippon Pharma Revenue in Diabetic Gastroparesis Business (2016-2021)
11.2.5 Sumitomo Dainippon Pharma Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Diabetic Gastroparesis Introduction
11.3.4 Abbott Laboratories Revenue in Diabetic Gastroparesis Business (2016-2021)
11.3.5 Abbott Laboratories Recent Development
11.4 Boston Scientific Corporation
11.4.1 Boston Scientific Corporation Company Details
11.4.2 Boston Scientific Corporation Business Overview
11.4.3 Boston Scientific Corporation Diabetic Gastroparesis Introduction
11.4.4 Boston Scientific Corporation Revenue in Diabetic Gastroparesis Business (2016-2021)
11.4.5 Boston Scientific Corporation Recent Development
11.5 C. R. Bard, Inc
11.5.1 C. R. Bard, Inc Company Details
11.5.2 C. R. Bard, Inc Business Overview
11.5.3 C. R. Bard, Inc Diabetic Gastroparesis Introduction
11.5.4 C. R. Bard, Inc Revenue in Diabetic Gastroparesis Business (2016-2021)
11.5.5 C. R. Bard, Inc Recent Development
11.6 Janssen Global Services, LLC
11.6.1 Janssen Global Services, LLC Company Details
11.6.2 Janssen Global Services, LLC Business Overview
11.6.3 Janssen Global Services, LLC Diabetic Gastroparesis Introduction
11.6.4 Janssen Global Services, LLC Revenue in Diabetic Gastroparesis Business (2016-2021)
11.6.5 Janssen Global Services, LLC Recent Development
11.7 Alfasigma SpA
11.7.1 Alfasigma SpA Company Details
11.7.2 Alfasigma SpA Business Overview
11.7.3 Alfasigma SpA Diabetic Gastroparesis Introduction
11.7.4 Alfasigma SpA Revenue in Diabetic Gastroparesis Business (2016-2021)
11.7.5 Alfasigma SpA Recent Development
11.8 Evoke Pharma
11.8.1 Evoke Pharma Company Details
11.8.2 Evoke Pharma Business Overview
11.8.3 Evoke Pharma Diabetic Gastroparesis Introduction
11.8.4 Evoke Pharma Revenue in Diabetic Gastroparesis Business (2016-2021)
11.8.5 Evoke Pharma Recent Development
11.9 Cadila Pharmaceuticals
11.9.1 Cadila Pharmaceuticals Company Details
11.9.2 Cadila Pharmaceuticals Business Overview
11.9.3 Cadila Pharmaceuticals Diabetic Gastroparesis Introduction
11.9.4 Cadila Pharmaceuticals Revenue in Diabetic Gastroparesis Business (2016-2021)
11.9.5 Cadila Pharmaceuticals Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Diabetic Gastroparesis Introduction
11.10.4 Sanofi Revenue in Diabetic Gastroparesis Business (2016-2021)
11.10.5 Sanofi Recent Development
11.11 Teva Pharmaceutical Industries Ltd
11.11.1 Teva Pharmaceutical Industries Ltd Company Details
11.11.2 Teva Pharmaceutical Industries Ltd Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd Diabetic Gastroparesis Introduction
11.11.4 Teva Pharmaceutical Industries Ltd Revenue in Diabetic Gastroparesis Business (2016-2021)
11.11.5 Teva Pharmaceutical Industries Ltd Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Diabetic Gastroparesis Introduction
11.12.4 Pfizer Revenue in Diabetic Gastroparesis Business (2016-2021)
11.12.5 Pfizer Recent Development
11.13 Vanda Pharmaceuticals
11.13.1 Vanda Pharmaceuticals Company Details
11.13.2 Vanda Pharmaceuticals Business Overview
11.13.3 Vanda Pharmaceuticals Diabetic Gastroparesis Introduction
11.13.4 Vanda Pharmaceuticals Revenue in Diabetic Gastroparesis Business (2016-2021)
11.13.5 Vanda Pharmaceuticals Recent Development
11.14 Allergan
11.14.1 Allergan Company Details
11.14.2 Allergan Business Overview
11.14.3 Allergan Diabetic Gastroparesis Introduction
11.14.4 Allergan Revenue in Diabetic Gastroparesis Business (2016-2021)
11.14.5 Allergan Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Diabetic Gastroparesis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drugs
Table 3. Key Players of Surgical Treatment Products
Table 4. Global Diabetic Gastroparesis Market Size Growth by Distribution Channel (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Diabetic Gastroparesis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Diabetic Gastroparesis Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Diabetic Gastroparesis Market Share by Regions (2016-2021)
Table 8. Global Diabetic Gastroparesis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Diabetic Gastroparesis Market Share by Regions (2022-2027)
Table 10. Diabetic Gastroparesis Market Trends
Table 11. Diabetic Gastroparesis Market Drivers
Table 12. Diabetic Gastroparesis Market Challenges
Table 13. Diabetic Gastroparesis Market Restraints
Table 14. Global Diabetic Gastroparesis Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Diabetic Gastroparesis Market Share by Players (2016-2021)
Table 16. Global Top Diabetic Gastroparesis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Gastroparesis as of 2020)
Table 17. Ranking of Global Top Diabetic Gastroparesis Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Diabetic Gastroparesis Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Diabetic Gastroparesis Product Solution and Service
Table 21. Date of Enter into Diabetic Gastroparesis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Diabetic Gastroparesis Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Diabetic Gastroparesis Revenue Market Share by Type (2016-2021)
Table 25. Global Diabetic Gastroparesis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Diabetic Gastroparesis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Diabetic Gastroparesis Market Size Share by Distribution Channel (2016-2021) & (US$ Million)
Table 28. Global Diabetic Gastroparesis Revenue Market Share by Distribution Channel (2016-2021)
Table 29. Global Diabetic Gastroparesis Forecasted Market Size by Distribution Channel (2022-2027) (US$ Million)
Table 30. Global Diabetic Gastroparesis Revenue Market Share by Distribution Channel (2022-2027) & (US$ Million)
Table 31. North America Diabetic Gastroparesis Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Diabetic Gastroparesis Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Diabetic Gastroparesis Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 34. North America Diabetic Gastroparesis Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 35. North America Diabetic Gastroparesis Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Diabetic Gastroparesis Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Diabetic Gastroparesis Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Diabetic Gastroparesis Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Diabetic Gastroparesis Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 40. Europe Diabetic Gastroparesis Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 41. Europe Diabetic Gastroparesis Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Diabetic Gastroparesis Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Diabetic Gastroparesis Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Diabetic Gastroparesis Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Diabetic Gastroparesis Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 46. Asia-Pacific Diabetic Gastroparesis Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Diabetic Gastroparesis Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Diabetic Gastroparesis Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Diabetic Gastroparesis Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Diabetic Gastroparesis Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Diabetic Gastroparesis Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 52. Latin America Diabetic Gastroparesis Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 53. Latin America Diabetic Gastroparesis Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Diabetic Gastroparesis Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Diabetic Gastroparesis Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Diabetic Gastroparesis Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Diabetic Gastroparesis Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 58. Middle East & Africa Diabetic Gastroparesis Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Diabetic Gastroparesis Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Diabetic Gastroparesis Market Size by Country (2022-2027) & (US$ Million)
Table 61. Medtronic Company Details
Table 62. Medtronic Business Overview
Table 63. Medtronic Diabetic Gastroparesis Product
Table 64. Medtronic Revenue in Diabetic Gastroparesis Business (2016-2021) & (US$ Million)
Table 65. Medtronic Recent Development
Table 66. Sumitomo Dainippon Pharma Company Details
Table 67. Sumitomo Dainippon Pharma Business Overview
Table 68. Sumitomo Dainippon Pharma Diabetic Gastroparesis Product
Table 69. Sumitomo Dainippon Pharma Revenue in Diabetic Gastroparesis Business (2016-2021) & (US$ Million)
Table 70. Sumitomo Dainippon Pharma Recent Development
Table 71. Abbott Laboratories Company Details
Table 72. Abbott Laboratories Business Overview
Table 73. Abbott Laboratories Diabetic Gastroparesis Product
Table 74. Abbott Laboratories Revenue in Diabetic Gastroparesis Business (2016-2021) & (US$ Million)
Table 75. Abbott Laboratories Recent Development
Table 76. Boston Scientific Corporation Company Details
Table 77. Boston Scientific Corporation Business Overview
Table 78. Boston Scientific Corporation Diabetic Gastroparesis Product
Table 79. Boston Scientific Corporation Revenue in Diabetic Gastroparesis Business (2016-2021) & (US$ Million)
Table 80. Boston Scientific Corporation Recent Development
Table 81. C. R. Bard, Inc Company Details
Table 82. C. R. Bard, Inc Business Overview
Table 83. C. R. Bard, Inc Diabetic Gastroparesis Product
Table 84. C. R. Bard, Inc Revenue in Diabetic Gastroparesis Business (2016-2021) & (US$ Million)
Table 85. C. R. Bard, Inc Recent Development
Table 86. Janssen Global Services, LLC Company Details
Table 87. Janssen Global Services, LLC Business Overview
Table 88. Janssen Global Services, LLC Diabetic Gastroparesis Product
Table 89. Janssen Global Services, LLC Revenue in Diabetic Gastroparesis Business (2016-2021) & (US$ Million)
Table 90. Janssen Global Services, LLC Recent Development
Table 91. Alfasigma SpA Company Details
Table 92. Alfasigma SpA Business Overview
Table 93. Alfasigma SpA Diabetic Gastroparesis Product
Table 94. Alfasigma SpA Revenue in Diabetic Gastroparesis Business (2016-2021) & (US$ Million)
Table 95. Alfasigma SpA Recent Development
Table 96. Evoke Pharma Company Details
Table 97. Evoke Pharma Business Overview
Table 98. Evoke Pharma Revenue in Diabetic Gastroparesis Business (2016-2021) & (US$ Million)
Table 99. Evoke Pharma Recent Development
Table 100. Cadila Pharmaceuticals Company Details
Table 101. Cadila Pharmaceuticals Business Overview
Table 102. Cadila Pharmaceuticals Diabetic Gastroparesis Product
Table 103. Cadila Pharmaceuticals Revenue in Diabetic Gastroparesis Business (2016-2021) & (US$ Million)
Table 104. Cadila Pharmaceuticals Recent Development
Table 105. Sanofi Company Details
Table 106. Sanofi Business Overview
Table 107. Sanofi Diabetic Gastroparesis Product
Table 108. Sanofi Revenue in Diabetic Gastroparesis Business (2016-2021) & (US$ Million)
Table 109. Sanofi Recent Development
Table 110. Teva Pharmaceutical Industries Ltd Company Details
Table 111. Teva Pharmaceutical Industries Ltd Business Overview
Table 112. Teva Pharmaceutical Industries Ltd Diabetic Gastroparesis Product
Table 113. Teva Pharmaceutical Industries Ltd Revenue in Diabetic Gastroparesis Business (2016-2021) & (US$ Million)
Table 114. Teva Pharmaceutical Industries Ltd Recent Development
Table 115. Pfizer Company Details
Table 116. Pfizer Business Overview
Table 117. Pfizer Diabetic Gastroparesis Product
Table 118. Pfizer Revenue in Diabetic Gastroparesis Business (2016-2021) & (US$ Million)
Table 119. Pfizer Recent Development
Table 120. Vanda Pharmaceuticals Company Details
Table 121. Vanda Pharmaceuticals Business Overview
Table 122. Vanda Pharmaceuticals Diabetic Gastroparesis Product
Table 123. Vanda Pharmaceuticals Revenue in Diabetic Gastroparesis Business (2016-2021) & (US$ Million)
Table 124. Vanda Pharmaceuticals Recent Development
Table 125. Allergan Company Details
Table 126. Allergan Business Overview
Table 127. Allergan Diabetic Gastroparesis Product
Table 128. Allergan Revenue in Diabetic Gastroparesis Business (2016-2021) & (US$ Million)
Table 129. Allergan Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Gastroparesis Market Share by Type: 2020 VS 2027
Figure 2. Drugs Features
Figure 3. Surgical Treatment Products Features
Figure 4. Global Diabetic Gastroparesis Market Share by Distribution Channel: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Diabetic Gastroparesis Report Years Considered
Figure 9. Global Diabetic Gastroparesis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Diabetic Gastroparesis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Diabetic Gastroparesis Market Share by Regions: 2020 VS 2027
Figure 12. Global Diabetic Gastroparesis Market Share by Regions (2022-2027)
Figure 13. Global Diabetic Gastroparesis Market Share by Players in 2020
Figure 14. Global Top Diabetic Gastroparesis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Gastroparesis as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Diabetic Gastroparesis Revenue in 2020
Figure 16. Global Diabetic Gastroparesis Revenue Market Share by Type (2016-2021)
Figure 17. Global Diabetic Gastroparesis Revenue Market Share by Type (2022-2027)
Figure 18. North America Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Diabetic Gastroparesis Market Share by Type (2016-2027)
Figure 20. North America Diabetic Gastroparesis Market Share by Distribution Channel (2016-2027)
Figure 21. North America Diabetic Gastroparesis Market Share by Country (2016-2027)
Figure 22. United States Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Diabetic Gastroparesis Market Share by Type (2016-2027)
Figure 26. Europe Diabetic Gastroparesis Market Share by Distribution Channel (2016-2027)
Figure 27. Europe Diabetic Gastroparesis Market Share by Country (2016-2027)
Figure 28. Germany Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Diabetic Gastroparesis Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Diabetic Gastroparesis Market Share by Distribution Channel (2016-2027)
Figure 37. Asia-Pacific Diabetic Gastroparesis Market Share by Region (2016-2027)
Figure 38. China Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Diabetic Gastroparesis Market Share by Type (2016-2027)
Figure 46. Latin America Diabetic Gastroparesis Market Share by Distribution Channel (2016-2027)
Figure 47. Latin America Diabetic Gastroparesis Market Share by Country (2016-2027)
Figure 48. Mexico Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Diabetic Gastroparesis Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Diabetic Gastroparesis Market Share by Distribution Channel (2016-2027)
Figure 53. Middle East & Africa Diabetic Gastroparesis Market Share by Country (2016-2027)
Figure 54. Turkey Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Diabetic Gastroparesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Medtronic Revenue Growth Rate in Diabetic Gastroparesis Business (2016-2021)
Figure 58. Sumitomo Dainippon Pharma Revenue Growth Rate in Diabetic Gastroparesis Business (2016-2021)
Figure 59. Abbott Laboratories Revenue Growth Rate in Diabetic Gastroparesis Business (2016-2021)
Figure 60. Boston Scientific Corporation Revenue Growth Rate in Diabetic Gastroparesis Business (2016-2021)
Figure 61. C. R. Bard, Inc Revenue Growth Rate in Diabetic Gastroparesis Business (2016-2021)
Figure 62. Janssen Global Services, LLC Revenue Growth Rate in Diabetic Gastroparesis Business (2016-2021)
Figure 63. Alfasigma SpA Revenue Growth Rate in Diabetic Gastroparesis Business (2016-2021)
Figure 64. Evoke Pharma Revenue Growth Rate in Diabetic Gastroparesis Business (2016-2021)
Figure 65. Cadila Pharmaceuticals Revenue Growth Rate in Diabetic Gastroparesis Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Diabetic Gastroparesis Business (2016-2021)
Figure 67. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Diabetic Gastroparesis Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Diabetic Gastroparesis Business (2016-2021)
Figure 69. Vanda Pharmaceuticals Revenue Growth Rate in Diabetic Gastroparesis Business (2016-2021)
Figure 70. Allergan Revenue Growth Rate in Diabetic Gastroparesis Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の胃不全麻痺治療市場規模・現状・予測（2021年-2027年） Gastroparesis is a disease in which the stomach cannot empty itself of food in a normal fashion. Symptoms include heartburn, nausea, vomiting, and feeling full quickly when eating. Treatments include medications and possibly surgery. Market Analysis and Insights: Global Gastroparesis Treatment Marke…- 世界の糖尿病性潰瘍治療市場規模・現状・予測（2021年-2027年） Diabetic foot ulcer is a major complication of diabetes mellitus, and probably the major component of the diabetic foot. Market Analysis and Insights: Global Diabetic Ulcers Treatment Market The global Diabetic Ulcers Treatment market size is projected to reach US$ 9041.7 million by 2027, from US$ 6…
- 世界の糖尿病アッセイ市場規模・現状・予測（2021年-2027年） Diabetics cause serious damage to the heart, blood vessels, eyes, kidney and nerves. High risk of cardiac disorders associated with diabetes demands efficient testing and diagnosis options. Diabetics assays are used for diagnostics and monitoring who are at risk of developing diabetes. Market Analys…
- 世界の抗糖尿病薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-diabetic Medication Market The global Anti-diabetic Medication market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の増殖糖尿病網膜症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Proliferative Diabetic Retinopathy Therapeutics Market The global Proliferative Diabetic Retinopathy Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accu…